SCHEMBL8806572

SCHEMBL8806572

COc1ccc(CCN(C)CCOc2ccc(NC(=O)c3cccc4c3Nc3ccccc3S4)cc2)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMPD1 P17405 2/20 0.44
▸ KDR P35968 3/20 0.43
▸ CYP3A4 P08684 4/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP2C8 P10632 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ KCNH2 Q12809 2/20 0.42
▸ MAPT P10636 3/20 0.41
▸ TP53 P04637 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8809261 0.88 BCHE (0.45) SMPD1CYP3A4CYP2C9KDM4EMEN1
SCHEMBL8809264 0.83 ABCG2 (0.41) SMPD1CYP3A4MAPTTP53TSHR
SCHEMBL8807068 0.77 KCNH2 (0.44) KDRCYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL8789872 0.77 ABCG2 (0.57) KDRCYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL8790216 0.76 ABCG2 (0.62) SMPD1KDRCYP3A4CYP2C19CYP2C8
SCHEMBL8808718 0.76 MAPT (0.48) KDRCYP3A4CYP2C19KCNH2MAPT
SCHEMBL8808236 0.75 MAPT (0.45) SMPD1KDRCYP3A4CYP2C19CYP2C8
SCHEMBL8789875 0.75 SMPD1 (0.45) SMPD1KDRKCNH2MAPTTP53
SCHEMBL8808344 0.74 ACHE (0.49) KDRCYP3A4CYP2C19MAPTTP53
SCHEMBL7168892 0.74 CYP3A4 (0.55) SMPD1CYP3A4CYP2C19CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback